DrugsControl Media Services

News Detail

NPPA rejects forms to fix retail price for formulations manufactured in Synokem’s facility (27-05-2024)

New Delhi, 27 May 2024: The National Pharmaceutical Pricing Authority (NPPA) has rejected the applications for retail price fixation of new drugs by certain companies, with a provision to file fresh application once the manufacturing company for these drugs, Synokem Pharmaceutica......
View Details

Source : Pharmabiz
National Pharmaceutical Pricing Authority NPPA retail price Synokem Pharmaceuticals Drugs Controller General (India) SLA CDSCO dapagliflozin vildagliptin sitagliptin teneliglipt telmisartan cilnidipine

Related News